Recursion director Blake Borgeson disposes of 30,000 shares for $97,500
RXRX•Director share sale reported
- Recursion Pharmaceuticals director Blake Borgeson sold 30,000 Class A common shares on Aug. 4 at $3.25.
- Direct holdings fell to 6,188,287 shares following the sale.
